Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1.

Gastrin is a gastrointestinal (GI) peptide that possesses potent trophic effects on most of the normal and neoplastic mucosa of the GI tract. Despite abundant evidence for these properties, the mechanisms governing gastrin-induced proliferation are still largely unknown. To elucidate the mechanisms by which gastrin might influence mitogenesis in gastric adenocarcinoma, we analyzed its effects on the human cell line AGS-B. Amidated gastrin (G-17), one of the major circulating forms of gastrin, induced a concentration-dependent increase in [3H]thymidine incorporation of cells in culture, with the maximum effective concentration occurring with 20 nM G-17. This effect was significantly attenuated by the gastrin-specific receptor antagonist L-365260. In addition, we found that G-17 induced a significant increase in the levels of cyclin D1 transcripts, protein, and promoter activity. The results of these studies indicate that gastrin appears to exert its mitogenic effects on gastric adenocarcinoma, at least in part, through changes in cyclin D1 expression.

[1]  R Kemler,et al.  beta-catenin is a target for the ubiquitin-proteasome pathway. , 1997, The EMBO journal.

[2]  R. Raychowdhury,et al.  Sp1 and CREB Mediate Gastrin-dependent Regulation of Chromogranin A Promoter Activity in Gastric Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[3]  A. Li,et al.  Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. , 1995, The New England journal of medicine.

[4]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[5]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Umar,et al.  Increased beta-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. , 2001, Cancer research.

[7]  R. Jaszewski,et al.  Differential Responsiveness of Proximal and Distal Colonic Mucosa to Gastrin , 1997, Peptides.

[8]  I. Weinstein,et al.  Effects of H. pylori infection of gastric epithelial cells on cell cycle control. , 2001, Frontiers in bioscience : a journal and virtual library.

[9]  H Clevers,et al.  TCF transcription factors: molecular switches in carcinogenesis. , 1999, Biochimica et biophysica acta.

[10]  J. Westwick,et al.  Oncogenic ras induces gastrin gene expression in colon cancer. , 1998, Gastroenterology.

[11]  G. Sachs,et al.  Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. , 2000, Gastroenterology.

[12]  A. Todisco,et al.  Glycine-Extended Gastrin Exerts Growth-Promoting Effects on Human Colon Cancer Cells , 1999, Molecular medicine.

[13]  I. Forgacs.  GASTROENTEROLOGY , 1988, The Lancet.

[14]  P. Zhou,et al.  Antisense to cyclin D1 reverses the transformed phenotype of human gastric cancer cells. , 1999, World journal of gastroenterology.

[15]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[16]  T. Wang,et al.  Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. , 2000, Gastroenterology.

[17]  K Willert,et al.  Beta-catenin: a key mediator of Wnt signaling. , 1998, Current opinion in genetics & development.

[18]  Y. Doki,et al.  Correlation of Beta-Catenin and Cyclin D1 Expression in Colon Cancers , 2001, Oncology.

[19]  L. Dethloff,et al.  Inhibition of gastrin-stimulated cell proliferation by the CCK-B/gastrin receptor ligand CI-988. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  C. Albanese,et al.  Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein. , 2000, Molecular cell biology research communications : MCBRC.

[21]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[22]  G. Dockray,et al.  Regulation of parietal cell migration by gastrin in the mouse. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[23]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[24]  M. Blaser,et al.  Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. , 1994, The Journal of clinical investigation.

[25]  L. Johnson,et al.  Mucosal DNA synthesis: a short term index of the trophic action of gastrin. , 1974, Gastroenterology.

[26]  G. Dockray,et al.  Stimulation of the gastrin-cholecystokinin(B) receptor promotes branching morphogenesis in gastric AGS cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[27]  M. Wolfe,et al.  Somatostatin stimulates gastrin mRNA turnover in dog antral mucosa. , 1990, The Journal of biological chemistry.

[28]  T. Wang,et al.  Processing and proliferative effects of human progastrin in transgenic mice. , 1996, The Journal of clinical investigation.

[29]  B. Geiger,et al.  Excess β‐catenin promotes accumulation of transcriptionally active p53 , 1999, The EMBO journal.

[30]  T. Solomon.  Trophic effects of pentagastrin on gastrointestinal tract in fed and fasted rats. , 1986, Gastroenterology.

[31]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[32]  D. Mischoulon,et al.  Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors , 1994, Molecular and cellular biology.

[33]  R. Nusse,et al.  β-catenin: a key mediator of Wnt signaling , 1998 .

[34]  S. J. Monahan,et al.  Inhibition of gastrin gene expression by somatostatin. , 1989, The Journal of clinical investigation.

[35]  J. Walsh,et al.  The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. , 1995, The New England journal of medicine.

[36]  Jörg Stappert,et al.  β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .

[37]  T. Wang,et al.  Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. , 1999, The Journal of clinical investigation.

[38]  T. Wang,et al.  Rat histidine decarboxylase promoter is regulated by gastrin through a protein kinase C pathway. , 1996, The American journal of physiology.

[39]  G. Friedman,et al.  Gastrin and colorectal cancer: a prospective study. , 1998, Gastroenterology.

[40]  W F Bodmer,et al.  Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Orita,et al.  Evaluation of cyclin D1 mRNA expression in gastric and colorectal cancers. , 1999, Research communications in molecular pathology and pharmacology.

[42]  W. Rutter,et al.  Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning. , 1987, Biochemistry.

[43]  M. Bissonnette,et al.  Elevated protein expression of cyclin D1 and Fra‐1 but decreased expression of c‐Myc in human colorectal adenocarcinomas overexpressing β‐catenin , 2002, International journal of cancer.

[44]  Z. Y. Chen,et al.  Gut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. , 2000, Nucleic acids research.

[45]  G. Baldwin,et al.  Gastrin, gastrin receptors and colorectal carcinoma , 1998, Gut.